PHILADELPHIA–(BUSINESS WIRE)– #biologics–VintaBio™, a technology-forward company, announced today that it has filed provisional patents with the US Patent Office describing its novel approach to manufacturing biotherapeutics using adherent culturing methods in a small-scale process. Improving upon the adherent manufacturing approaches used for FDA-approved gene therapies, such as Zolgensma™ and Luxturna™, VintaBio has designed a purpose-built process that reduces large operational footprints that restric